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Introduction
The World Health Organization (WHO) End TB strategy, aiming to reduce tuberculosis (TB) incidence and TB mortality by 90% and 95% respectively by 2035, poses major challenges to TB control programmes in low TB incidence settings (defined as countries with an annual incidence of 10 / 100,000) 1 . The goal in these settings is to achieve pre-elimination (defined as an annual incidence of <1 / 100,000) and to move towards elimination by 2035 2 . In order to achieve this, the setting-specific challenges in TB control in these low-incidence countries must be addressed. This requires special attention to specific populations at highest risk of TB disease, among whom much of the disease burden is now concentrated [2] [3] [4] .
Vulnerable populations (including homeless persons, high-risk drug users, prisoners, asylum seekers, and other marginalized populations) contribute a disproportionate number of TB cases in lowincidence settings [1] [2] [3] . Previous studies have attempted to quantify these disease burdens. Studies of homeless people have shown that the prevalence of active TB is heterogeneous, ranging from 200-7,700/100,000, with increased prevalence found in studies using chest radiography-based diagnosis, and in settings with higher general population TB prevalence 5 . Using systematic review and metaanalysis, Dolan et al. estimated that approximately 2,800/100,000 of incarcerated individuals globally have active TB 6 . Among high-risk drug users in London, UK, the prevalence of TB was estimated at Recent global and European guidance highlights a clear need to strengthen TB control efforts among vulnerable groups in low-incidence settings 1, 3 . Approaches addressing this may include active case finding initiatives, in order to promote early case-detection of TB disease, along with interventions that improve linkage and retention in TB care, to increase treatment completion. This narrative review will discuss active case finding and adherence interventions when targeting homeless persons, highrisk drug users, prisoners, and other marginalised populations in low-incidence settings. Other important risk-groups include recent migrants and people living with HIV; these are beyond the scope of this review, as they are included in other articles in this series 14, 18 . A literature search was conducted to support this review (Box 1). Definitions of key terms used in this review, including active case finding and adherence, are included in Box 2.
Active case finding in risk groups in the TB pre-elimination era

Screening tools and algorithms
Active case finding involves the systematic identification of individuals with suspected active TB, in a pre-determined target group 19 . This requires the implementation of a pre-defined screening algorithm and may utilise tools including symptom questionnaires, chest radiographs (either mobile or off-site), or sputum diagnostics. Desirable qualities of a screening algorithm include high sensitivity, low cost, high throughput and rapid turnaround time. Table 1 summarises the sensitivity of available screening tools.
Symptom screening is generally thought to be of little value in risk groups in low-incidence settings due to limitations of poor sensitivity and specificity (particularly among populations with high prevalence of smoking, alcohol and drug use) 19, 20 . Data evaluating the use of symptom screening as the sole initial screening tool are therefore scarce, though it may be used in combination with other methods.
Chest radiography, previously deployed for mass radiography screening for TB 21 , has re-emerged as a valuable initial screening tool among risk groups in recent years due to a number of strengths. These include:-the development of mobile digital radiography; relatively low cost; high throughput; high diagnostic accuracy; and immediate availability of results [22] [23] [24] [25] . Chest radiography, regardless of symptoms, has therefore been the initial screening test of choice in the majority of recent studies evaluating active case finding interventions among risk groups in low-incidence settings. It should be noted, however, that sensitivity is reduced in populations with a high prevalence of advanced HIV infection -which may be relevant to some high-risk groups (e.g. injecting drug users) targeted by 26 . An example screening algorithm using a mobile x-ray unit (MXU) is demonstrated in Figure 1 .
Sputum diagnostic tools for TB include smear microscopy, culture and molecular tests. Smear microscopy, while cheap and relatively fast to perform, is limited by poor sensitivity so is of little value as a screening tool 19 . Mycobacterial culture remains the gold-standard for the microbiological diagnosis of TB. It has generally been thought to have a limited role in active case finding among hard-to-reach groups in low-incidence settings due to the limitations of being dependent upon individuals' ability to produce good quality sputum samples, and slow turnaround time (up to 6 weeks) -which raises the challenge of locating positive cases after their initial screening 23 Another approach to active case finding among risk groups is the combination of a symptom screen and tuberculin skin-test (TST) as the initial screening tools, with chest radiography performed if either is positive [30] [31] [32] [33] . While both methods have low sensitivity for active TB when used in isolation, this approach relies on a high negative predictive value when both are negative. However, drawbacks include low specificity, and the requirement for at least two visits to read results. Interferon-gamma release assays (IGRA) also continue to be evaluated as tests for active TB 34 , but are also impaired by limited sensitivity, high cost and the requirement of a specialist laboratory 35 . Both TST and IGRA are therefore more commonly applied when the primary goal is screening for LTBI rather than TB disease. Table 2 summarises published studies evaluating active case finding interventions among high-risk groups in low-incidence settings.
Mobile x-ray unit screening
Multiple studies have evaluated MXU screening approaches. The Find & Treat service in London, UK, involves a MXU screening intervention, targeting a mixed hard-to-reach population that includes homeless persons, prisoners, high-risk drug users and asylum seekers [36] [37] [38] . The service was initiated Netherlands. Over a 4-year period, 28 active TB cases were diagnosed by the intervention (prevalence 327/100,000); the authors also reported a reduction in RFLP-clustering over a time, suggesting a decline in recent transmission 45 . Implementation of the intervention as part of a wider comprehensive social rehabilitation programme for homeless people and drug users was associated with a marked reduction in TB incidence among these risk groups in Rotterdam over time. This resulted in a subsequent reduction in efficiency and yield of the intervention, which was therefore deemed no longer necessary and withdrawn at the end of 2014 46 .
In a systematic review and meta-analysis of 16 studies from Western Europe, Japan, USA and Australia, the pooled prevalence of active TB from chest radiography screening of homeless people was estimated as 931/100,000 (range 434 -3,015) 22 .
Other active case finding approaches
Jensen et al. implemented spot sputum screening (using microscopy and culture) among a mixed . Two of these studies reported a reduction in TB incidence in US cities over the duration of the intervention, though other biomedical and socioeconomic factors may have contributed to these trends 32, 33 . Screening of inmates on entry to prisons has been evaluated in Spanish and USA studies.
Algorithms used on entry in these studies have generally included an initial symptom screen and TST, followed by chest radiograph if either is positive, and have shown a prevalence of active TB of 68 -2,706/100,000 [49] [50] [51] [52] [53] [54] [55] . However, performing a chest radiograph (rather than an initial symptom questionnaire and TST) as the initial screening test on prison entry has been associated with a reduction of exposure time to infectious TB cases (by expediting isolation) 53, 54 , and a reduction in cost per case diagnosed 56 .
Coverage & uptake of screening
Ensuring adequate screening coverage and uptake must also be a priority for any active case finding intervention. Few studies have attempted to report coverage of screening programmes, which remains challenging to quantify in hard-to-reach groups due to the frequently mobile nature of these populations 48, 57 . Acceptance and uptake of screening are also rarely reported, with uptake ranging from 14-87% in the absence of specific incentives 40, 41, 43, [58] [59] [60] [61] . Uptake is likely to be better with mobile (rather than off-site) screening programmes, though evidence for specific strategies to improve uptake is currently limited.
Aldridge et al. conducted a cluster randomised-controlled trial to examine whether volunteer peer educators (with direct experience of TB and/or homelessness) improved uptake of MXU screening at hostels in London. No difference in uptake was observed (40% in the intervention group; 45% in the control group), though the study was limited by the intervention having previously been in place at 'standard care' sites prior to the study being commenced, and therefore may have resulted in residual confounding and a reduction in the difference seen between the intervention and control arms 59 . Other studies from the USA have shown an increase in attendance to off-site chest radiograph referral with a .
Yield of screening
The weighted mean estimated number needed to screen has been estimated as 133 (range 22-1778), 1180 (4-2945) and 158 (108-252) when targeting homeless persons, prisoners and drug users respectively in low-incidence settings 19 . However, these estimates are heterogeneous, reflecting differences in TB incidence between different risk groups, and between different settings. Active case finding interventions therefore require a targeted, setting-specific approach. This should be based on local epidemiological data that can identify those populations with sufficient disease burden to justify the provision of resources to enable focused interventions. Policymakers may use surveillance data, or even targeted prevalence surveys, to identify high-risk populations on a local level, and determine the potential yield and thus cost-effectiveness of proposed active case finding interventions.
Future directions and research priorities for active case finding interventions
Following a 'positive' initial screening test (e.g. a mobile chest radiograph in most recent studies), the most widely utilised screening algorithm involves referral to a TB service for further investigation as the next step [ Figure 1 ]. Sputum may be sent for microbiological testing in parallel to this referral. A problem with this approach is the risk that they may not attend the TB service for further assessment,
This initial loss-to-follow-up (which occurs prior to TB diagnosis) has been estimated as being as high as 31% in London 37 and 50% in Sydney, Australia
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. Implementation of 'point-of-care' molecular technology to enable a microbiological diagnosis on the day of initial screening following a suggestive chest radiograph is therefore attractive. Xpert MTB/RIF offers the potential to provide this in approximately two hours, using an automated platform 28 . This assay also allows the prompt identification of possible multidrug-resistance, through the detection of rifampicin-resistance conferring mutations. However, there are currently no studies published that evaluate the implementation of molecular diagnostics in a mobile outreach setting in a low-incidence country; data addressing this, including newer generations of the Xpert MTB/RIF assay or similar rapid molecular diagnostics, are therefore needed.
Technology may also be applied to MXU screening algorithms through the implementation of automated x-ray readers (e.g. CAD4TB), which may reduce reliance on trained human readers while addressing issues with inter-reader reprodubility 63 [ Figure 1 ]. However, data validating the software for use in low-incidence settings and in a mobile screening unit are required prior to widespread rollout of the technology.
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As discussed above, the variable prevalence of TB among high-risk groups in low-incidence settings means that active case finding interventions require a tailored approach based on local epidemiological data, followed by monitoring and evaluation of cost-effectiveness and impact at a local level. The roll-out of universal whole genome sequencing (WGS) in some low-incidence settings may allow this to be done with greater resolution in future. When used in combination with conventional epidemiological methods, WGS may enable surveillance systems to identify sites and individuals that carry a high-risk of onward transmission earlier and more precisely than epidemiological methods alone have allowed, particularly in the context of outbreaks [64] [65] [66] . Prospective studies that evaluate the potential impact of real-time genomic data on local TB control policies are awaited.
Qualitative studies have suggested that further increases in TB awareness, reduction in stigmatisation and improvements in perceived access to healthcare are all required to improve usage of TB services by risk groups 67 ; further research is clearly needed to inform and evaluate strategies to address these needs. Engaging key partners, such as staff in prisons and shelters, is also integral to maximise uptake of screening programme targeting these groups.
In addition to identifying active TB cases, consideration of testing and treating for LTBI among highrisk groups is recommended (after exclusion of TB disease) in international and some national guidance in low-incidence settings 68, 69 . Studies evaluating the yield of LTBI screening when implemented among risk groups in parallel to active TB case finding, along with acceptance and completion of LTBI treatment, and impact on incident TB risk are needed. Furthermore, risk groups for TB overlap with those for other diseases -including HIV, hepatitis B and hepatitis C 70 . Combining active case finding and linkage to care for these services for individuals in hard-to-reach groups may therefore be cost-effective by capitalising upon a shared resource infrastructure, though data to support this are currently lacking.
Treatment adherence in risk groups in the TB pre-elimination era
There have been few studies evaluating the role of interventions in improving adherence and active TB treatment completion among individuals from risk groups [ Table 3 ]. Of these, 8 studies have evaluated enhanced case management interventions (including directly observed therapy (DOT), since this is not offered universally in low TB-incidence settings), while one has studied financial incentives. when administered by peers 75 .
Incentives
Data on the use of financial incentives to improve adherence to therapy for TB in risk groups are lacking. In one study, Bock et al. studied the impact of financial incentives on treatment completion among a mixed hard-to-reach population in Georgia, USA, and found that DOT attendance improved .
While electronic reminder systems (e.g. short message service (SMS)) may also be of some benefit in improving adherence to appointments and treatment for TB services, the impact of such interventions on adherence and treatment completion in risk groups in low-incidence settings has not been evaluated 81 .
Conclusions
Vulnerable groups -including homeless persons, prisoners, high-risk drug users and other marginalised groups -are a major priority for TB control programmes in low-incidence countries due to their disproportionate disease burden, ongoing high risk of transmission, and poor treatment outcomes. Interventions targeting these groups should aim to increase timely case-detection, and improve linkage-to-care and completion of therapy.
Interventions must be tailored to address local priorities, based on knowledge of regional epidemiology and risk groups, and must be monitored and evaluated at a local level. Mobile x-ray units appear to be effective and cost-effective 38 in achieving timely case-detection, and have been associated with reductions in proxy measures of transmission 44, 45 . Implementation of new technology -including molecular diagnostics at the point-of-care (to expedite microbiological TB diagnosis), and universal whole genome sequencing (to supplement epidemiological data and identify transmission foci promptly) -may aid existing interventions to improve effectiveness in the future.
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Interventions to improve treatment completion among these risk groups must also be tailored to individuals and may include enhanced case management (by both healthcare workers and peers), the provision of supervised accommodation for homeless persons, and supervised treatment (particularly when delivered in community and by peers). Incentives may also have a role, though evidence for this among risk groups are lacking. VOT is an extremely promising technology and is currently under evaluation as a tool to improve adherence in hard-to-reach groups. Integrating both active case finding and strategies to improve adherence into outreach interventions is likely to be cost-effective, by capitalising on shared resource infrastructure, while integrating testing and treatment for other diseases with overlapping risk profiles (e.g. HIV, hepatitis B and hepatitis C) into TB outreach services may improve overall cost-effectiveness further.
However, high quality data evaluating the impact of active case finding initiatives and (in particular)
interventions to improve treatment adherence among risk groups in low-incidence settings are generally lacking. More high-quality studies are required that examine the impact of such interventions on timely case-detection, treatment outcomes, risk of onward transmission, and maximising uptake of the interventions themselves. If the End TB strategy goals of achieving preelimination and moving towards elimination in low-incidence settings by 2035 are to be reached, a concerted and prolonged effort will be required to reach these vulnerable groups, engage and retain them in care to the point of treatment completion. If we are serious about elimination, these efforts must be maintained even in light of falling cost-effectiveness, as TB incidence (and thus screening yield) declines. Finally, while this review has focused on biomedical interventions that aim to reduce the burden of TB disease among risk groups, we should not forget the imperative need to address the issue at its true core. We must continue to strive to improve access to healthcare among risk groups, while also reducing the size of risk group populations themselves, by implementing policies that seek to reduce health inequity and social exclusion directly.
Box 1: Search Strategy
A literature search was performed using Medline (1946 -September 2017) to supplement this narrative, state of the art review. In short, two search sets were created and then combined using 'and', using comprehensive search terms for (1) 'tuberculosis' and (2) 'homeless' or 'drug users' or 'prisoners' or 'vulnerable populations'. This yielded 2,317 articles. Additional articles were identified by reviewing references of included studies and review articles, and by consulting experts in the field.
Original research articles investigating active case finding initiatives or interventions to promote adherence among the aforementioned risk groups in low TB-incidence settings (defined as incidence <10/100,000) were identified. Studies that focused on contact tracing or specific outbreak investigations, or identifying and treating latent TB infection (LTBI) only, were excluded. After review of titles, abstracts and full-texts as appropriate, 45 relevant articles were identified (Tables 2 &   3) , with a narrative approach to synthesis. 19, 82 ) Active case finding -systematic identification of people with suspected active TB in a predetermined target group.
Box 2: Definitions (adapted from
Adherence -extent to which a patient's history of therapeutic drug-taking coincides with the prescribed treatment.
Low TB incidence country -country with annual TB incidence 10 / 100,000 persons.
Passive case finding -a patient-initiated pathway to TB diagnosis that starts with a person presenting spontaneously to healthcare services.
Risk group -any group of people in which the prevalence or incidence of TB is significantly higher than in the general population.
Screening coverage -proportion of total eligible target population who complete screening.
Screening test -a test that distinguishes people with a high likelihood of having active TB from people who are highly unlikely to have active TB.
Screening uptake -proportion of those offered screening who complete it. Observational cost-effectiveness analysis of ACF using MXU intervention. Compared to passively-detected cases identified through routine surveillance.
Case-detection intervention was cost-effective (£18,000-£26,000/QALY gained) Homeless -10 /822 active TB (1.2%); prisoners 7/22,920 active TB (0.03). Estimated that LTBI treatment of homeless persons and jail inmates will avert 11.9 and 7.9 TB cases at a cost of $14,350 and $34,761 per TB case, respectively Cost of screening with miniature chest radiography estimated as $9,600/case identified Table 3 : Summary of included studies of interventions to improve adherence and treatment completion among selected risk groups from low tuberculosis (TB) incidence countries. Studies categorised as (a) Studies using enhanced case management; (b) studies using DOT; (c) studies using incentives. Studies listed by year of publication (reverse chronological order).
(ACF = active case finding; DOT = directly observed therapy). 
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